COMMUNIQUÉS West-GlobeNewswire

-
Nutrify Today Introduces a Trio of Innovations to Strengthen NutrifyGenie AI Capabilities
10/12/2024 - 20:00 -
Crossject launches reserved capital increase and warrants issuance for an aggregate amount of at least €7m
10/12/2024 - 19:15 -
Crossject annonce une augmentation de capital et une emission de bons de souscription d’actions reservee à une catégorie d’investisseurs pour un montant total minimum de 7 millions d’euros
10/12/2024 - 19:15 -
CARBIOS announces the initiation of coverage of its stock by STIFEL
10/12/2024 - 18:00 -
CARBIOS annonce l’initiation de couverture de son titre par STIFEL
10/12/2024 - 18:00 -
Federally Qualified Health Centers May Be Making Unlawful Reports to the National Practitioner Data Bank, according to Journal of American Physicians and Surgeons
10/12/2024 - 17:59 -
Monica Lewinsky visite le laboratoire Primeks Medical d’Agnivesh Agarwal à Istanbul
10/12/2024 - 17:47 -
Enterome’s Immunotherapy EO2463 Shows Early Clinical Response in Newly Diagnosed Follicular Lymphoma Suggesting a Potential Alternative to 'Watchful Waiting'
10/12/2024 - 17:43 -
Le CEPI et Accumulus Synergy s’associent pour renforcer l’accès équitable à l’information et accélérer l’accès aux vaccins
10/12/2024 - 16:58 -
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
10/12/2024 - 16:18 -
COVID Non-pharmaceutical Interventions Were Harmful Authoritarian Overreach, according to Journal of American Physicians and Surgeons
10/12/2024 - 16:02 -
Thought Leadership & Innovation Foundation Celebrates the Launch of Autism Knowledge Gateway
10/12/2024 - 16:02 -
Neuronetics and Greenbrook TMS Announce Closing of Transaction
10/12/2024 - 16:00 -
Soda Health Adds Walgreens to Network of Integrated Retailers, Serving More than 100 Million Medicare Advantage and Medicaid Members
10/12/2024 - 16:00 -
Brain Cancer Canada Awards a $50,000 Grant to Discover How to Use the Body’s Own Immune Cells to Attack Pediatric Brain Cancers
10/12/2024 - 16:00 -
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
10/12/2024 - 15:55 -
Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024
10/12/2024 - 15:39 -
India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
10/12/2024 - 15:25 -
HWH International Inc. and Guangzhou Inbot Technology Ltd Announce Strategic Partnership to Drive Global Robotics Expansion
10/12/2024 - 15:20
Pages